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Abstract
PURPOSE: The purpose of this study was to evaluate the effectiveness of an education session to
promote adherence to the United States Preventive Services Task Force (USPSTF) recommendation and
Clinical Practice Guidelines for Treating Tobacco Use and Dependence by providers.
METHODS: A retrospective and prospective record review was used to evaluate an education session for
providers in tobacco use screening, providing cessation counseling, prescribing medication for tobacco
cessation and sending out referrals for tobacco cessation at one primary care clinic in Louisville, KY.
Education sessions were held from August 1, 2018 to August 14, 2018. The sample consisted of 200
randomly selected patient medical records from among current tobacco users. The retrospective study
included 100 chart reviews from January 1, 2018 to March 31, 2018 and the prospective chart review
included 100 chart reviews from August 15, 2018 to September 15, 2018.
RESULTS: The group demographics did not differ significantly, demonstrating similarities among
variables. There was no change in the rate of documentation of tobacco use screened by the providers
during the pre- and post-intervention phases (31.3% vs. 31.3%). There were no statistically significant
differences in documentation of tobacco use screening rates when comparing provider types. Both the
pre- and post-intervention groups did not statistically differ with regard to the percentage of smoking
cessation medications being prescribed.
CONCLUSION: This project demonstrated a need for improvement in provider documentation in
adherence with USPSTF recommendation and Treating Tobacco Use and Dependence Guidelines. In
addition, there is a need for more thorough documentation of tobacco screening among known tobacco
users in the primary care clinic. Further research is needed, using a larger study sample, to identify a
continuous trend on screening rates.

Keywords: Tobacco cessation, primary care, providers, education, recommendation, guidelines
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The Effect of a Provider Education Program on Tobacco Use in an Adult Population in the Primary Care
Setting
Introduction
Tobacco use is one of the most preventable causes of morbidity and mortality in the United
States, yet it continues to be a serious primary health care issue (U.S Department of Health and Human
Services [DHHS], 2014). According to the World Health Organization (WHO), more than 1.1 billion
people smoked tobacco in 2015 (WHO, 2017). The consequences of tobacco use affect everyone in the
community, not only the people who smoke. Consequences of not routinely screening for tobacco use and
counseling tobacco users in cessation, include an increased risk of lung, heart, and vascular diseases
(DHHS, 2014). In the United States, twenty percent of all deaths are caused by cigarette smoking
(American Cancer Society [ACS], 2017). Tobacco users have a decreased life expectancy compared to
non-tobacco users. There are approximately 480,000 premature deaths annually and more than 300 billion
dollars are spent in healthcare expenditures each year in the United States from disease related to tobacco
use (Jamal et al., 2015). Hence, tobacco use could be considered the deadliest and costliest public health
threat to our nation.
The fight for tobacco cessation is crucial considering its severe health consequences. Tobacco use
in any form, i.e. smoking, chewing or secondhand exposure, causes serious health issues. Smoking
tobacco causes cardiovascular disease, lung cancer, and other lung diseases, such as chronic obstructive
pulmonary disease (COPD) and asthma (DHHS, 2014). Secondhand smoke exposure can also cause
asthma, birth defects, sudden infant death syndrome, chronic ear infections in kids, and frequent lung
infections (Centers for Disease Control and Prevention [CDC], 2017). Because of the high risk of disease
from tobacco use and exposure, reducing cigarette smoking by adults, 18 years and older, to 12 % is one
of the objectives for Healthy People 2020 (Office of Disease Prevention and Health Promotion [ODPHP],
2014).
In 2016, the rate of cigarette smoking in the U.S was 15.5% (Odani et al., 2018); with a higher
smoking prevalence among males compared to females, 17.5% and 13.5 %, respectively (Jamal et al.,
2
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2018). Unfortunately, Kentucky has one of the highest rates of cigarette smoking in the U.S., with 21.1%
of adult Kentuckians currently smoking cigarettes, and 26.2% using any form of tobacco (Odani et al.,
2018). Based on these statistics it is of critical importance to address tobacco use. The purpose of this
study was to evaluate the effectiveness of an education session to promote provider adherence to the
United States Preventive Services Task Force (USPSTF, 2015) recommendation and Clinical Practice
Guidelines for Treating Tobacco Use and Dependence (Fiore, Jaen, Baker, et al., 2008).
Background
Nicotine from smoking is a very addictive substance, both physically and mentally, causing
tobacco cessation to be increasingly difficult (Chaney & Sheriff, 2012). Tobacco use and its dependence
is a chronic disease that often leads to several attempts to quit (Fiore et al., 2008). Patients who stop
smoking may require multiple treatment approaches from their primary care provider (PCP) because of
the risk of withdrawal symptoms and relapse (CDC, 2017). “Although, 68% of the adult population

who smoke indicate a desire to quit, only 55% make an attempt in the past year, and only 7.4%
have recent success (Babb, 2017). This finding suggests that there is a high proportion of individuals
who want to quit tobacco and it is crucial for the PCP to assess and help these patients quit successfully.
Thus, PCPs are in a key position to screen for tobacco use and engage their patient population in tobacco
cessation treatments.
By screening for tobacco use, the PCP can work with patients to help them to understand the
chronicity of the disease process and provide evidence-based interventions to assist them in cessation.
The United States Preventive Services Task Force (USPSTF) recommends asking the patient about
tobacco use and subsequently providing tobacco cessation interventions by counseling, pharmacotherapy
and implementing strategies for tobacco cessation (USPSTF, 2015). The PCP can influence significant
outcomes in tobacco cessation programs by encouraging patients through motivational interviewing
strategies and evidenced-based treatment interventions to successfully quit tobacco use (DHHS, 2014).
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The Clinical Practice Guidelines for Treating Tobacco Use and Dependence: 2008 were
generated from systematic reviews of the best available scientific literature and is recommended by the
USPSTF to be used to identify the most appropriate pharmacotherapy and counseling options for the
screened patient (Fiore et al., 2008). Evidence suggests that combining both counseling (motivational
interviewing strategies, telephone quit-line) and medication for tobacco cessation are most effective to
assist smokers in cessation (Fiore et al., 2008). Nicotine replacement therapy (NRT) for tobacco cessation
has been shown to be more successful than a placebo or no treatment at all (Fiore et al., 2008). The nonnicotinic based medications, like varenicline and bupropion, are also suggested by the clinical practice
guidelines for successful quitting. Along with medication, behavioral counseling is very important for
successful quitting. When behavioral counseling therapy is initiated, tobacco users are four times more
likely to quit (Chaney & Sheriff, 2012).
The “Five-A” model of brief intervention is an evidence-based tobacco cessation strategy that
includes asking if the patient uses tobacco, advising the patient to quit, assessing for willingness to quit,
assisting to quit and arranging for follow-up and support (Fiore et al., 2008). When PCPs are consistent in
providing tobacco cessation interventions and discussing the harmful effects of continuous tobacco use at
each visit, there is often a decrease in tobacco use as compared with no education provided (LaniadoLaborin, 2010). One study found that one out of four patients will get the opportunity for tobacco
cessation interventions in an outpatient visit (Jamal, Dube, & King 2015). By the combination of the 5-A
model of brief intervention, education and evidence-based recommendation, the primary care provider
can make a positive impact on tobacco cessation.
Purpose
The purpose of this study was to evaluate the effectiveness of an education program for providers
to promote adherence to the USPSTF recommendation and Clinical Practice Guidelines for Treating
Tobacco Use and Dependence at a primary care clinic in Louisville, Kentucky. The study objectives were
to identify the percentage rate of documentation for tobacco use at a primary care clinic between January

4
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1, 2018 and March 31, 2018 and to use this pre-intervention data to compare with the post-intervention
period of August 15, 2018 through September 15, 2018. The specific objectives that were focused on
prior to and after implementation of the education session were:
1.

Identify the percentage rate of documentation of screening for tobacco use by the PCP.

2.

Identify the percentage rate of documentation of counseling, prescribing of tobacco
cessation medications.

3.

Identify the referral rates of smoking cessation.
Methods

This was a single center, quasi-experimental, pre and post-intervention study. This study included
both retrospective and prospective features. The study consisted of three phases: Pre-intervention phase,
intervention phase, and post-intervention phase. The pre-intervention phase consisted of a retrospective
review of data performed on 100 randomly selected patient charts who were current smokers and were
seen from January 1, 2018, through March 31, 2018. The intervention phase took place between August
1, 2018 through August 14, 2018 and consisted of educating all providers at the chosen clinic about the
USPSTF recommendation and Treating Tobacco Use Dependence Guidelines and how to document this
in the electronic medical record (EMR). The post-intervention phase consisted of a prospective review of
data from 100 randomly selected patient charts who were current smokers and were seen from August 15,
2018 through September 15, 2018.
Setting
The primary care clinic chosen for this study is located in Louisville, Kentucky. Approximately
2,200 patients are seen every month. The clinic is open five days a week and provides care by
appointment only to adult patients, ages 18 and older. There are five physicians and five nurse
practitioners who practice in this office and focus on management of acute and chronic diseases and
preventive care. Two providers were excluded from the study because they either did not practice at this
location during the pre-intervention phase so there would not be comparative data available or they did
not attend the education session provided.
5
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Sample
The sample consisted of medical records of 100 randomly selected patients for the preintervention phase and 100 randomly selected patients for the post-intervention phase. Both preintervention and post-intervention data were compared. Inclusion criteria consisted of adult patients who
were 18 years and older at the time of the visit, active cigarette smokers, patients who were seen by the
eight providers who consented to the study, and patients who were charged based on the following
Current Procedural Terminology (CPT) codes for new, established and preventive visits(99202, 99203,
99204, 99205, 99212, 99213, 99214, 99215, 99385, 99386, 99387, 99395, 99396, 99397). The exclusion
criteria consisted of any patients who admitted to using smokeless tobacco (chewing tobacco and vaping)
and any patients who were seen by the other two providers in the office. The following variables were
collected in both the pre and post intervention chart reviews: Age, gender, race, type of visit (annual,
episodic, or follow-up), type of health insurance, type of provider (physician or nurse practitioner), and
CPT codes used. Documentation of tobacco screening, patient education, medication prescription and
referral were also reviewed.
The Intervention
All providers from the primary care clinic were asked to attend one of ten face-to-face
educational sessions that were available from August 1, 2018 through August 14, 2018. During the
session the project was explained to providers and those who consented were asked at that time to
voluntarily sign an informed consent. Providers included in the study were four physicians and four nurse
practitioners. Education consisted of detailed information on tobacco cessation based on materials from
the USPSTF recommendation and Treating Tobacco Use and Dependence Guidelines. A printed
educational handout for tobacco cessation and correct EMR documentation was created (Refer to
Appendix A). A tip sheet for how to add the referral for smoking cessation in the EMR was provided,
along with CPT codes to use for reimbursement by commercial insurance and Medicare for tobacco
use/abuse (Refer to Appendix A).
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Data collection
Approvals from the University of Kentucky Institutional Review Board (IRB) and the
Norton Healthcare Office of Research and Administration (NHORA) were obtained prior to the collection
of data. After the intervention period, a random sample of patient charts were obtained from NHORA
through the Norton Healthcare electronic patient database. During data collection, patient records were
accessed using the patient medical record number (MRN), data were abstracted based on the list below,
and then transferred to an electronic spreadsheet. The demographic variables obtained from the charts
included age, gender, race, type of visit (annual, episodic, or follow-up), type of health insurance, type of
provider (physician or nurse practitioner), and CPT codes used. Each patient’s chart was assessed for
tobacco use screening by looking at the provider’s documentation in the “History of Present Illness”
(HPI) section of the chart. If screening was performed it was coded as ‘1’ for Yes and if screening was
not performed it was coded as ‘2’ for No. Education on smoking cessation by providers was also
assessed. Data for this measure were obtained from the “Tobacco Screening and Education Section” of
the EMR. Charts with a documentation of education provided were coded as ‘1’ and those without were
coded as ‘2’. Another measure that was evaluated was whether a Federal Drug Administration (FDA)
approved medication for smoking cessation was prescribed. The data for this measure were obtained from
the “Plan” section of the EMR. FDA approved medications for smoking cessation include the nicotine
patch, gum, lozenge, inhaler, or nasal spray, varenicline, and bupropion. Charts with a documentation of
any of these medications prescribed were coded as ‘1’ and those without were coded as ‘2’. A list of
specific medications prescribed was also obtained. The last measure assessed for documentation in the
EMR was if a referral to smoking cessation resources was initiated. Data for this measure were obtained
from the “Referral” section of the chart. This measure was based on the documentation of referral to any
tobacco treatment program, such as the USPSTFs telephone quit line or the American Lung Association’s
Freedom from Smoking classes. Charts with a documentation of any referrals initiated were coded as ‘1’
and those without were coded as ‘2’.

7

EFFECT OF PROVIDER EDUCATION PROGRAM ON TOBACCO USE

Data Analysis
Data were analyzed using SPSS statistics software (Version 23.0). Descriptive statistics,
including frequency distributions and percentages were used to summarize the demographic variables
data for the pre and post intervention of the patient demographics. The Chi-Square Test of Association
was used to evaluate for significance of association between variables. All data analysis was conducted
using Microsoft Excel.
Results
Sample Characteristics
A total of 200 patient charts were reviewed. The pre-intervention sample consisted of charts from
100 randomly selected patients and 100 randomly selected patients for the post-intervention sample. Only
96 charts met the inclusion criteria in the pre-intervention phase. The four charts excluded from the study
were due to patients having a status as a former smoker, smokeless tobacco user, and deceased. Similarly,
in the post-intervention phase 99 charts met the inclusion criteria. The excluded chart was due to status as
a smokeless tobacco user. Almost half of the samples in each phase were between the ages of 41-60 and
about a quarter were in the other age groups. The majority of patients were female (57.3%) and Caucasian
(80.2%), followed by African American and Hispanic (11.5%, 5.2% respectively). The pre-intervention
and post-intervention demographic characteristics as to age group, gender, race/ethnicity, type of health
insurance, type of visit, and type of provider are presented in Table 1. The group demographics did not
differ significantly, demonstrating similarities. There were not statistically significant differences in group
demographics between the pre-intervention and post-intervention groups.
Documentation of Screening
There was no change in the rate of documentation of tobacco use screening by the providers
during the pre-intervention (31.3%) and post-intervention phases (31.3%) p=0.992. There were no
statistically significant differences in documentation of tobacco use screening rates when comparing
provider types. The pre-intervention sample demonstrated a higher number of patients who were screened
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by nurse practitioners (59.4%) as opposed to the post-intervention sample who was screened more
frequently by physicians (52.5%). Episodic visits were shown to be the most frequent type of visit during
both phases, but documentation of tobacco screening was the lowest during these encounters. Annual
visits were actually the least frequent type of visit encountered but had the highest adherence rate in
documentation of tobacco screening.
Counseling, Medications, and Referrals
Documentation of counseling by the providers did not differ between the pre-interventions and
post-intervention samples (26.0% vs. 31.3%, p=0.416). As a whole, both the pre-intervention (10.4%) and
post-intervention (12.1%) groups did not statistically differ with regard to the percentage of smoking
cessation medications being prescribed (p=0.707) Figure 2 illustrates the comparison between both
groups and medications prescribed. There was no difference between the pre-intervention (n=1) and postintervention (n=0) groups with regard to referrals being sent to tobacco cessation programs (See Table 2).
Discussion
This study aimed to increase documentation of tobacco use screening in the primary care clinic
after an education session on the USPSTF recommendation and Treating Tobacco Use and Dependence
guideline was provided to all consented providers. Other aims of this study included increasing the
provider’s documentation of counseling, prescribing of tobacco cessation medications, and initiating
referrals to tobacco cessation programs. After comparing the pre-intervention data to the post-intervention
data there were no statistically significant differences among any of the study’s variables.
Overall, the adherence rate for documentation of tobacco use screening was 31.3% at both phases
of the study. This suggests that only a third of the known smokers during these visits had documentation
of being screened for tobacco use by the providers. The highest adherence rate in both phases of the study
for tobacco screening documentation was found to be during annual visits. Annual visits were actually the
least frequent type of visit encountered but had the highest adherence rate in documentation of tobacco
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screening. According to the Center for Medicare and Medicaid Services (CMS), the annual “wellness”
visit should include a personalized prevention plan to help prevent disease and disability based on the
patient’s health and risk factors (CMS, 2016). There are many modifiable and non-modifiable risk factor
screenings that are covered during this visit, including tobacco use cessation counseling. If these visits are
focused mainly on prevention then it is conceivable that 100% of all annual visits seen should include the
documentation of tobacco use screening and counseling.
From 2005-2010 the CDC conducted a national survey that found that on average adults were
screened for tobacco use during 65.6% of all ambulatory care visits. Of those who were identified as
tobacco users, 20.7% received tobacco cessation counseling (CDC, 2014). The counseling rate of this
study sample in both phases was higher than the national average. Although this clinic ranked higher than
the national average on counseling, all known smokers, regardless of their readiness to quit, should be
receiving counseling on the effects and consequences of continued tobacco use. When providers are
consistent in providing tobacco cessation counseling and interventions at each visit, there is often a
decrease in tobacco use as compared with no education provided (Laniado-Laborin, 2010).
The Healthy People 2020 nationwide initiative goal for cigarette smoking is 12%, the most
current data show that Kentucky is at 21.1% for cigarette smoking (ODPHP, 2014; Odani et al., 2018).
This demonstrates that there is an opportunity for growth in primary care clinics within the state of
Kentucky to improve tobacco use screenings and to provide evidenced-based counseling and
interventions for successful tobacco cessation.
Limitations and Implications for Future Research
There were several limitations identified in the design of this study. Although data were collected
from a large primary care clinic, the study was limited to the specific Louisville, Kentucky region. A
larger, multi-clinic, multi-regional comparison would help increase generalizability.
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The intervention phase was limited to only two weeks for the providers and could have impacted
how adequately they understood the material. Since the intervention consisted of a one-time education
session and was initiated within a short period of time, implementation of the study objectives within the
provider’s practice could have been difficult for them during their normal routine hours. As shown by the
evidence in this study there was no single referral made for tobacco cessation in the post-intervention
phase.
Another limitation was the length and reach of this study. The education session and chart review
were performed solely by the primary investigator. To see an impact and further comparison of the study
objectives, this study could be replicated for at least one year and at multiple clinics.
Further research should include identification of provider barriers to documentation of tobacco
use screening, counseling, pharmacotherapy, and referrals. According to McBride et al., some perceived
barriers to provider documentation include limited time allotted for each patient visit, lack of priority for
and knowledge of the provider, and lack of teamwork within the office (1997).
Conclusion
The continuous use of tobacco has serious consequences to our nation’s health. Tobacco use is
the single most preventable cause of disease, disability and death in the United States. Primary care
practices should place more emphasis on adopting a system-wide practice change on screening,
counseling, medication and referral for all tobacco users and appropriately documenting those
interventions. Tobacco use screening and cessation counseling is recognized as one of three most
effective and efficacious preventive health actions that can be undertaken in a clinical setting (Agency for
Healthcare Research and Quality [AHRQ], 2018). Meeting the recommended requirements for tobacco
screening rates is a difficult task and should be confronted with a multidisciplinary approach within the
practice.
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Table 1. Demographic characteristics of the study sample
Pre-implementation
(N=96) n (%)

Post-implementation
(N=99)
n (%)

P

Age
18-40
41-60
61 and above

26 (27.1)
46 (47.9)
24 (25.0)

37 (37.4)
41 (41.4)
21 (21.2)

0.307

Gender
Male
Female

41 (42.7)
55 (57.3)

36 (36.4)
63 (63.6)

Race/Ethnicity
Caucasian
African American
Hispanic
Other

77 (80.2)
11 (11.5)
5 (5.2)
3 (3.1)

73 (74.5)
20 (20.4)
1 (1.0)
4 (4.1)

33 (34.4)
33 (34.4)
30 (31.2)
0 (0)

38 (38.4)
35 (35.4)
24 (24.2)
2 (2)

14 (14.6)
45 (46.9)
37 (38.5)

20 (20.2)
47 (47.5)
32 (32.3)

57 (59.4)
39 (40.6)

47 (47.5)
52 (52.5)

Health Insurance
Commercial
Medicaid
Medicare
No Insurance
Type of Visit
Annual
Episodic
Follow-up
Type of Provider
Nurse Practitioner
Physician
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0.365

0.138

0.375

0.492
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Table 2. Comparison of documentation, counseling, medication and referral for smoking cessation before
and after an education intervention.

Documentatation of
tobacco use:
Yes
No
Counseling
Yes
No
Medication
Yes
No
Referral
Yes
No

Pre-Education (n=96)
n (%)

Post-Education (n=99)
n (%)

P

30 (31.3)
66 (68.8)

31 (31.3)
68 (68.7)

0.992

25 (26.0)
71 (74.0)

31 (31.3)
68 (68.7)

0.416

10 (10.4)
86 (89.6)

12 (12.1)
87 (87.9)

0.707

1 (1.0)
95 (99.0)

0 (0)
99 (100)

0.309
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Figure 1. Adherence to tobacco screening based on type of visit
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Figure 2. Number of FDA-approved tobacco cessation medications prescribed
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Appendix A
Educational Handout and Tip Sheets for EMR Documentation
Education to Primary Care Clinic, Louisville, Kentucky.
Sunita Gurung, DNP-student 2018, University of Kentucky

Project Aim:
Decrease the rate of smoking in the NCMA patient group
Goal
o Increase provider knowledge on current smoking guidelines.
o Screen patient for smoking status
o Discuss smoking status and readiness to quit
o Increase patient knowledge on the effects of smoking and different ways to quit.
o Provide patient the tobacco cessation resources.
Background
o One of the most preventable reason for morbidity and mortality in the United States.
o 1.1 billion people smoked tobacco in 2015 and killing over seven million people around the
world.
o Twenty percent death are caused by cigarette smoking.
o More than 300 billion dollars cost in healthcare expenditure
o 480,000 premature deaths in the United States
o Tobacco use in Kentucky 29.6%
o An estimated 70% of smokers have expressed desired to quit.
Health risk related to smoking:
o COPD
o Stroke
o Lung Cancer
o Peripheral Vascular Disease
o Diabetes
o Cancer of Bladder, Cervix, Colon, Rectum, Esophagus, Liver, Pancreas, Stomach.
o Fertility, pregnancy, fetal complication.
o Infection
o Dental, vision hearing problems.
Tobacco Cessation Strategies
The United States Preventative Task Force (USPSTF) had issued a Grade A recommendation that
healthcare provider should screen patients on tobacco use and provide tobacco cessation interventions to
those who use tobacco products (USPSTF, 2015). Healthcare provider can utilize the “5-A” framework
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for the counseling strategy because this strategy gives the healthcare provider to assess the patient
smoking history, number of packs of cigarette smoking and readiness to quit (USPSTF, 2014):
1)

Ask about the tobacco use.

2)

Advice to quit through clear personalized messages.

3)

Assess willingness to quit.

4)

Assist to quit.

5)

Arrange follow- up and support.

The USPSTF, 2015 also recommend counseling directly with patients for longer or multiple
sessions. Telephone counseling (1-800-QUIT-NOW) “quit lines” also improve the cessation rates. Quit
are free service and is available 24/7. Patient can speak with trained person. Patient can contact at any
point during the process of quit time or after quitting.
Pharmacotherapy: Combination of counseling and medication are more effective than either alone. FDA
approved nicotine replacement therapy includes, sustained release bupropion and Varenicline.
The seven first line medication (5 nicotine and 2 non-nicotine) reliably increase long-term smoking
abstinence rates. Bupropion SR, Nicotine gum, Nicotine inhaler, Nicotine lozenge. Nicotine nasal spray,
Nicotine patch, Varenicline.
Implementation/Strategies: Set a quit date. Inform family, friends, coworkers about quit date. Inform
patient in Nicotine withdrawal for couple week. Remove all the tobacco from the environment.
U.S Preventative Services Task Forces:
Tobacco Smoking Cessation in Adults, Including Pregnant Women: Behavioral and Pharmacotherapy
Interventions
Population

Nonpregnant adults
age ≥18 y

Pregnant women age
≥18 y
Provide behavioral
interventions for
cessation.
Grade: A

Pregnant women age
≥18 y

Recommendation

Provide
pharmacotherapy and
behavioral
interventions for
cessation.
Grade: A

Assessment

The 5 A's framework is a useful strategy for engaging patients in smoking cessation discussions.
The “5 A's” include: 1) Asking every patient about tobacco use, 2) Advising them to quit, 3)
Assessing their willingness to quit, 4) Assisting them with quitting, and 5) Arranging follow-up.
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Pharmacotherapy
interventions: No
recommendation.
Grade: I statement

All adults age ≥18 y
ENDS: No
recommendation.
Grade: I statement
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Behavioral
Counseling
Interventions

Behavioral
interventions alone
(in-person behavioral
support and
counseling, telephone
counseling, and selfhelp materials) or
combined with
pharmacotherapy
substantially improve
achievement of
tobacco cessation.

Behavioral
interventions
substantially improve
achievement of
tobacco smoking
abstinence, increase
infant birthweight,
and reduce risk for
preterm birth.

Pharmacotherapy
Interventions

Pharmacotherapy
interventions,
including NRT,
bupropion SR, and
varenicline—with or
without behavioral
counseling
interventions—
substantially improve
achievement of
tobacco cessation.

Balance of Benefits
and Harms

The USPSTF
concludes with high
certainty that the net
benefit of behavioral
interventions and
FDA-approved
pharmacotherapy for
tobacco cessation,
alone or in
combination, is
substantial.

Other Relevant
USPSTF
Recommendations

The USPSTF recommends that primary care clinicians provide interventions, including
education or brief counseling, to prevent the initiation of tobacco use in school-aged children and
adolescents. This recommendation is available at http://www.uspreventiveservicestaskforce.org.

The USPSTF
concludes with high
certainty that the net
benefit of behavioral
interventions for
tobacco cessation on
perinatal outcomes
and smoking
abstinence is
substantial.

There is inadequate or
no evidence on the
benefits of NRT,
bupropion SR, or
varenicline to achieve
tobacco cessation in
pregnant women or
improve perinatal
outcomes in infants.

There is inadequate
evidence on the
benefit of ENDS to
achieve tobacco
cessation in adults or
improve perinatal
outcomes in infants.

The USPSTF
concludes that the
evidence on
pharmacotherapy
interventions for
tobacco cessation is
insufficient because
of a lack of studies,
and the balance of
benefits and harms
cannot be determined.

The USPSTF
concludes that the
evidence on the use of
ENDS for tobacco
cessation is
insufficient, and the
balance of benefits
and harms cannot be
determined

For a summary of the evidence systematically reviewed in making these recommendations, the full recommendation
statement, and supporting documents, please go to http://www.uspreventiveservicestaskforce.org.
Disclaimer: Recommendations made by the USPSTF are independent of the U.S. government. They should not be
construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of
Health and Human Services.
Current as of: September 2015
Internet Citation: Clinical Summary: Tobacco Smoking Cessation in Adults, Including Pregnant Women:
Behavioral and Pharmacotherapy Interventions. U.S. Preventive Services Task Force. September 2015.
https://www.uspreventiveservicestaskforce.org/Page/Document/ClinicalSummaryFinal/tobacco-use-in-adults-andpregnant-women-counseling-and-interventions1
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Fiore MC, Jaén CR, Baker TB, et al. (2008). US Department of Health and Human Services, “Treating
Tobacco Use and Dependence: 2008 Update”. Ten Key Guideline Recommendations:

The overarching goal of these recommendations is that clinicians strongly recommend the use of
effective tobacco dependence counseling and medication treatments to their patients who use
tobacco, and that health systems, insurers, and purchasers assist clinicians in making such
effective treatments available.
1.Tobacco dependence is a chronic disease that often requires repeated intervention and multiple
attempts to quit. Effective treatments exist, however, that can significantly increase rates of longterm abstinence.
2.It is essential that clinicians and health care delivery systems consistently identify and
document tobacco use status and treat every tobacco user seen in a health care setting.
3.Tobacco dependence treatments are effective across a broad range of populations. Clinicians
should encourage every patient willing to make a quit attempt to use the counseling treatments
and medications recommended in this Guideline.
4.Brief tobacco dependence treatment is effective. Clinicians should offer every patient who uses
tobacco at least the brief treatments shown to be effective in this Guideline.
5.Individual, group, and telephone counseling are effective, and their effectiveness increases
with treatment intensity. Two components of counseling are especially effective, and clinicians
should use these when counseling patients making a quit attempt: Practical counseling
(problemsolving/skills training) Social support delivered as part of treatment.
6.Numerous effective medications are available for tobacco dependence, and clinicians should
encourage their use by all patients attempting to quit smoking—except when medically
contraindicated or with specific populations for which there is insufficient evidence of
effectiveness (i.e., pregnant women, smokeless tobacco users, light smokers, and adolescents).
Seven first-line medications (5 nicotine and 2 non-nicotine) reliably increase long-term smoking
abstinence rates:
Bupropion SR
Nicotine gum
Nicotine inhaler
Nicotine lozenge
Nicotine nasal spray
Nicotine patch
Varenicline
Clinicians also should consider the use of certain combinations of medications identified as
effective in this Guideline.
7.Counseling and medication are effective when used by themselves for treating tobacco
dependence. The combination of counseling and medication, however, is more effective than
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either alone. Thus, clinicians should encourage all individuals making a quit attempt to use both
counseling and medication.
8.Telephone quitline counseling is effective with diverse populations and has broad reach.
Therefore, both clinicians and health care delivery systems should ensure patient access to
quitlines and promote quitline use.
9.If a tobacco user currently is unwilling to make a quit attempt, clinicians should use the
motivational treatments shown in this Guideline to be effective in increasing future quit attempts.
10. Tobacco dependence treatments are both clinically effective and highly cost-effective relative
to interventions for other clinical disorders. Providing coverage for these treatments increases
quit rates. Insurers and purchasers should ensure that all insurance plans include the counseling
and medication identified as effective in this Guideline as covered benefits.
A comparison of the findings of the updated Guideline with the 2000 Guideline reveals the
considerable progress made in tobacco research over the brief period separating these two
publications. Tobacco dependence increasingly is recognized as a chronic disease, one that
typically requires ongoing assessment and repeated intervention. In addition, the updated
Guideline offers the clinician many more effective treatments strategies than were identified in
the original Guideline. There now are seven different first-line effective agents in the smoking
cessation pharmacopoeia, allowing the clinician and patient many different medication options.
In addition, recent evidence provides even stronger support for counseling (both when used alone
and with other treatments) as an effective tobacco cessation strategy; counseling adds to the
effectiveness of tobacco cessation medications, quitline counseling is an effective intervention
with a broad reach, and counseling increases tobacco cessation among adolescent smokers.
Finally, there is increasing evidence that the success of any tobacco dependence treatment
strategy cannot be divorced from the health care system in which it is embedded. The updated
Guideline contains new evidence that health care policies significantly affect the likelihood that
smokers will receive effective tobacco dependence treatment and successfully stop tobacco use.
For instance, making tobacco dependence treatment a covered benefit of insurance plans
increases the likelihood that a tobacco user will receive treatment and quit successfully. Data
strongly indicate that effective tobacco interventions require coordinated interventions. Just as
the clinician must intervene with his or her patient, so must the health care administrator, insurer,
and purchaser foster and support tobacco intervention as an integral element of health care
delivery. Health care administrators and insurers should ensure that clinicians have the training
and support to deliver consistent, effective intervention to tobacco users.
One important conclusion of this Guideline update is that the most effective way to move
clinicians to intervene is to provide them with information regarding multiple effective treatment
options and to ensure that they have ample institutional support to use these options. Joint actions
by clinicians, administrators, insurers, and purchasers can encourage a culture of health care in
which failure to intervene with a tobacco user is inconsistent with standards of care.

Smoking and Tobacco Use Cessation Counseling Visit Documentation for Billing.
Excludes for group
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•

99406- Intermediate, minimum of 3 min, up to 10 minutes
99407- Intensive, (greater than) 10 minutes
G0436- For Medicare; minimum of 3 min, up to 10 min (this will occur on the backend)
G0437- For Medicare; (greater than) 10 min (this will occur on the backend)
Qualifications of charge for patients:
•
•
•

1.) Who use tobacco, regardless of whether they have signs/symptoms of tobacco-related disease;
2.) Who are competent and alert at the time that counseling is provided; and,
3.) Whose counseling is furnished by a qualified physician or other Medicare-recognized
practitioner

Documentation should include:
•
•
•
•
•
•
•
•
•
•

A diagnosis to support billing of the code (Ex. Tobacco use/Abuse - Z72.0)
The amount of the patients tobacco use
The History of use (current/dependent/past)
The amount of time spent on tobacco cessation counseling
The context in which it was provided; suggested actions and motivational counseling
Specific validated interventions of assessing readiness for change and barriers to change
Advise a change in behavior
Arranging for services and follow-up
Up to 4 cessation counseling sessions ( 1 attempt =up to 4 sessions)
Two cessation counseling attempts (or up to 8 cessation counseling sessions) are allowed every
12 months (for Medicare, commercial payers vary)

Referral to Smoking Cessation Program
This tip sheet describes the process of submitting a referral order to the Smoking Cessation Program.
Provider Workflow
1. Within an Office Visit, Orders Only or Telephone encounter, select the Meds & Orders
section.
2. Select the

New Order button to open the office-level preference list.

3. If you have an established user preference list, de-select the “Only Favorites” checkbox.

4. Expand the

Referrals preference list on the left, and select Referrals.
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5. Select the Smoking Cessation Program order.

6. Click Accept.
7. The Smoking Cessation Program is now listed under the Unsigned Orders section of
Medications & Orders. Select the summary sentence to open the Order Composer.

8. The Smoking Cessation Program order’s “To dept spec” field defaults to ‘Prevent and
Wellness’.

You Can Also...
 Search for the Smoking Cessation Program order.
1. In the Medications & Orders section, click the New Order button.

2. The Preference List Browser opens on the Browse tab.

3. Search for the Smoking Cessation Program in the search box.
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